Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

被引:249
|
作者
Vogel, Jacob W. [1 ]
Iturria-Medina, Yasser [1 ]
Strandberg, Olof T. [2 ]
Smith, Ruben [2 ,3 ]
Levitis, Elizabeth [1 ]
Evans, Alan C. [1 ]
Hansson, Oskar [2 ,3 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[2] Lund Univ, Clin Memory Res Unit, Lund, Sweden
[3] Skane Univ Hosp, Memory Clin, Lund, Sweden
基金
加拿大健康研究院; 瑞典研究理事会; 美国国家卫生研究院; 欧洲研究理事会;
关键词
COGNITIVE DECLINE; IN-VIVO; NEURODEGENERATIVE DISEASES; F-18-AV-1451; PET; MODEL; DEPOSITION; BINDING; PROPAGATION; ASSOCIATION; CONNECTOME;
D O I
10.1038/s41467-020-15701-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tau is a hallmark pathology of Alzheimer's disease, and animal models have suggested that tau spreads from cell to cell through neuronal connections, facilitated by beta -amyloid (A beta). We test this hypothesis in humans using an epidemic spreading model (ESM) to simulate tau spread, and compare these simulations to observed patterns measured using tau-PET in 312 individuals along Alzheimer's disease continuum. Up to 70% of the variance in the overall spatial pattern of tau can be explained by our model. Surprisingly, the ESM predicts the spatial patterns of tau irrespective of whether brain A beta is present, but regions with greater A beta burden show greater tau than predicted by connectivity patterns, suggesting a role of A beta in accelerating tau spread. Altogether, our results provide evidence in humans that tau spreads through neuronal communication pathways even in normal aging, and that this process is accelerated by the presence of brain A beta. The tau protein is theorized to spread transneuronally in Alzheimers disease, though this theory remains unproven in humans. Our simulations of epidemic-like protein spreading across human brain networks support this theory, and suggest the spreading dynamics are modified by beta -amyloid
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
    Lenka Hromadkova
    Chae Kim
    Tracy Haldiman
    Lihua Peng
    Xiongwei Zhu
    Mark Cohen
    Rohan de Silva
    Jiri G. Safar
    Cell & Bioscience, 13
  • [42] Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons
    Mccluskey, Leo F.
    Geser, Felix
    Elman, Lauren B.
    Van Deerlin, Vivianna M.
    Robinson, John L.
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (5-6) : 466 - 472
  • [43] Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study
    Schoonhoven, Deborah N.
    Coomans, Emma M.
    Millan, Ana P.
    van Nifterick, Anne M.
    Visser, Denise
    Ossenkoppele, Rik
    Tuncel, Hayel
    van der Flier, Wiesje M.
    Golla, Sandeep S., V
    Scheltens, Philip
    Hillebrand, Arjan
    van Berckel, Bart N. M.
    Stam, Cornelis J.
    Gouw, Alida A.
    BRAIN, 2023, 146 (10) : 4040 - 4054
  • [44] Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease
    Herdy, Joseph R.
    Traxler, Larissa
    Agarwal, Ravi K.
    Karbacher, Lukas
    Schlachetzki, Johannes C. M.
    Boehnke, Lena
    Zangwill, Dina
    Galasko, Doug
    Glass, Christopher K.
    Mertens, Jerome
    Gage, Fred H.
    CELL STEM CELL, 2022, 29 (12) : 1637 - +
  • [45] Phosphorylated tau interactome in the human Alzheimer's disease brain
    Drummond, Eleanor
    Pires, Geoffrey
    MacMurray, Claire
    Askenazi, Manor
    Nayak, Shruti
    Bourdon, Marie
    Safar, Jiri
    Ueberheide, Beatrix
    Wisniewski, Thomas
    BRAIN, 2020, 143 : 2803 - 2817
  • [46] Hallmark cellular pathology of Alzheimer’s disease induced by mutant human tau expression in cultured Aplysia neurons
    Or A. Shemesh
    Micha E. Spira
    Acta Neuropathologica, 2010, 120 : 209 - 222
  • [47] Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons
    Shemesh, Or A.
    Spira, Micha E.
    ACTA NEUROPATHOLOGICA, 2010, 120 (02) : 209 - 222
  • [48] Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model
    Castillo-Carranza, Diana L.
    Guerrero-Munoz, Marcos J.
    Sengupta, Urmi
    Hernandez, Caterina
    Barrett, Alan D. T.
    Dineley, Kelly
    Kayed, Rakez
    JOURNAL OF NEUROSCIENCE, 2015, 35 (12): : 4857 - 4868
  • [49] Analysis of N-glycans of pathological tau:: possible occurrence of aberrant processing of tau in Alzheimer's disease
    Sato, Y
    Naito, Y
    Grundke-Iqbal, I
    Iqbal, K
    Endo, T
    FEBS LETTERS, 2001, 496 (2-3) : 152 - 160
  • [50] Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer's Disease
    Xu, Linlin
    Ding, Yuxun
    Ma, Feihe
    Chen, Yue
    Chen, Guidong
    Zhu, Lin
    Long, Jiafu
    Ma, Rujiang
    Liu, Yang
    Liu, Jianfeng
    Huang, Fan
    Shi, Linqi
    NANO TODAY, 2022, 43